23 reports

Big data collection is one essential step.

  • Digestive System Disorder
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation

Big data collection is one essential step.

  • Digestive System Disorder
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation

AS OF MARCH 2009, IT WAS IN PRECLINICAL STAGE FOR LISTERIOSIS AND MALARIA.

  • Digestive System Disorder
  • Hospital
  • Immunotherapy
  • Therapy
  • TaiwanJ Pharmaceuticals Co., Ltd.
  • Clinical Trial profile. 130 Trial Title
  • Clinical Trial profile. 124 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • Gastrointestinal Drug
  • World

## ## ## ## ## ## Germany ## ## ## ## ## ## Japan ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## Italy ## ## ## ## ## ## Canada Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a tim

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • Gastrointestinal Drug
  • Pathology
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Therapy
  • World
  • Product Initiative
  • GlaxoSmithKline plc

Project ##: immune checkpoint inhibitors.

  • Ambulatory Care
  • Digestive System Disorder
  • Therapy
  • United States
  • Capricor Therapeutics, Inc.
  • GILEAD SCIENCES EXPANDS LICENSING AGREEMENT WITH STRIDES SHASUN
  • GILEAD SCIENCES ENTERS INTO LICENSING AGREEMENT WITH CIPLA

The company' s products find applications in the treatment of diseases such as AIDS, malaria and tuberculosis.

  • Digestive System Disorder
  • HIV AIDS
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.
  • CONSTIPATION - PIPELINE BY DONG-A ST CO LTD, H1 2019
  • CONSTIPATION - PIPELINE BY BRAINTREE LABORATORIES INC, H1 2019

It also offers diagnostic solutions for identification of Malaria, dengue combo, HBsAg, anti-HBs, Hepatitis C, HIV ##/ ##, Syphilis and Ebola Ag diseases.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • DWJ-206 - DRUG PROFILE

The molecules developed by Companies in Pre-Registration, Phase II, Phase I, IND/ CTA Filed and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • Digestive System Disorder
  • Pharmaceutical
  • United States
  • Litigation And Patent
  • AstraZeneca PLC

IBS is one of the most common gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Company Operations
  • RedHill Biopharma Ltd.
  • FEATURED NEWS & PRESS RELEASES

Diarrhea - Overview Diarrhea - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DIARRHEA, H## 2019 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DIARRHEA, H## 2019 Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ## ## Unknown ## ## Total ##

  • Digestive System Disorder
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • CONSTIPATION - PIPELINE BY DONG-A ST CO LTD, H2 2019
  • CONSTIPATION - PIPELINE BY ENTERIN INC, H2 2019

It also offers diagnostic solutions for identification of Malaria, dengue combo, HBsAg, anti-HBs, Hepatitis C, HIV ##/ ##, Syphilis and Ebola Ag diseases.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • United States
  • Product Initiative
  • Clinical Trial profile. 99 Trial Title
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • IRRITABLE BOWEL SYNDROME - PIPELINE BY DONG-A ST CO LTD, H2 2019
  • IRRITABLE BOWEL SYNDROME - PIPELINE BY COSMO PHARMACEUTICALS NV, H2 2019

It also offers diagnostic solutions for identification of Malaria, dengue combo, HBsAg, anti-HBs, Hepatitis C, HIV ##/ ##, Syphilis and Ebola Ag diseases.

  • Digestive System Disorder
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • SMALL MOLECULE TO INHIBIT SCD-1 FOR NONALCOHOLIC STEATOHEPATITIS - DRUG PROFILE

SMALL MOLECULES FOR MALARIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description SMALL MOLECULES FOR MALARIA DAIICHI SANKYO COMPANY, LIMITED NA MEDICINES FOR MALARIA VENTURE SMALL MOLECULES ARE UNDER DEVELOPMENT

  • Cancer
  • Digestive System Disorder
  • Monoclonal Antibody
  • Therapy
  • Daiichi Sankyo Company
  • DIARRHEA - PIPELINE BY CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO LTD
  • DIARRHEA - PIPELINE BY BHARAT BIOTECH LTD

IT PROVIDES RESEARCH PROGRAMS ON BIO-ANTIBIOTICS, COMBINATION PROBIOTICS, LYSOSTAPHIN, CHIKUNGUNYA VACCINE, TYPHOID CONJUGATE VACCINE, ORAL ROTAVIRUS VACCINE, MALARIA VACCINE AND LIQUID RABIES VACCINES, AMONG OTHERS.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Company
  • Product Initiative
  • PARTNERSHIPS

GlobalData ImmusanT Inc, reported one medical equipment deal worth $## million in YTD 2017.

  • Digestive System Disorder
  • United States
  • Company
  • Deals & Alliance
  • ImmusanT, Inc.

## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy Source: GlobalData' s Pharma Intelligence Center Clinical

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • Pharmaceutical
  • World

Phase ## clinical trials of a malaria transmission-blocking vaccine and a hookworm vaccine are underway, both of which are non-commercial products fully funded by third parties.

  • Digestive System Disorder
  • Pharmaceutical
  • Research And Development
  • Therapy
  • Genfit SA

Patients will be randomized ##:##:## to one of placebo, ## mg of OCA, or ## mg of OCA, taken once daily.

  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

In vitro and in vivo studies have shown potent activity against S. pneumoniae as well as an extended spectrum of activity against community-acquired methicillin resistant S. aureus (CA-MRSA), streptococci, haemophilus, enterococci, Mycobacterium avium and in animal models of malaria.

  • Clinical Trial
  • Digestive System Disorder
  • World
  • Product Initiative
  • Gilead Sciences, Inc.

PNEUMONIAE AS WELL AS AN EXTENDED SPECTRUM OF ACTIVITY AGAINST CA-MRSA, STREPTOCOCCI, HAEMOPHILUS, ENTEROCOCCI, MYCOBACTERIUM AVIUM AND IN ANIMAL MODELS OF MALARIA.

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • World
  • Product Initiative